REGENXBIO Inc.

RGNX·NasdaqGS·Healthcare
Compare
7.77−0.30 (−3.72%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours7.90+0.13 (+1.67%)Oct 12, 4:53 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close8.07
Open8.11
Day range7.768.29
52-week range5.4616.19
Off day high−6.27%
Off 52-week high−52.01%
Volume2.03M
Avg. volume (3M)1.49M
Market cap512.92M
EPS (TTM)-3.78
Forward P/E-2.61
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.13
Shares outstanding66.01M
Short interest15.41% of float
Earnings dateAug 6, 2026 (est.)
Analyst target23.58
Profit margin−112.58%

Against its peers

Compare in full ›
RGNX FDMT IRD OCGN NGNE DSGN
Market cap 512.92M 718.17M 386.03M 321.21M 489.08M 682.77M
P/E (TTM) — — — — — —
Forward P/E -2.6 -3.2 -6.5 -3.7 -4.3 -6.7
Price/book 5.9 1.8 -29.6 -19.3 1.8 3.4
Dividend yield — — — — — —
1-year change −28.84% +37.85% +132.50% −40.25% −16.51% +64.80%
Today −3.72% −2.48% −0.22% −0.87% −7.42% −6.35%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to REGENXBIO's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT · Biotechnology 718.17M 13.00 −2.48%
Opus Genetics, Inc.IRD · Biotechnology 386.03M 4.6400 −0.22%
Ocugen, Inc.OCGN · Biotechnology 321.21M 0.9472 −0.87%
Neurogene Inc.NGNE · Biotechnology 489.08M 24.44 −7.42%
Design Therapeutics, Inc.DSGN · Biotechnology 682.77M 10.91 −6.35%
Lexeo Therapeutics, Inc.LXEO · Biotechnology 249.55M 3.0400 −5.88%
MeiraGTx Holdings plcMGTX · Biotechnology 996.93M 10.38 −2.90%
Rocket Pharmaceuticals, Inc.RCKT · Biotechnology 272.24M 2.4800 −3.13%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Bright Minds Biosciences Inc.DRUG · New York, NY 532.76M 54.01 −0.07%
Puma Biotechnology, Inc.PBYI · Los Angeles, CA 531.17M 10.29 0.00%
Aclaris Therapeutics, Inc.ACRS · Wayne, PA 529.92M 3.6000 −6.01%
Crescent Biopharma, Inc.CBIO · Waltham, MA 537.14M 14.46 −3.02%
Neurogene Inc.NGNE · New York, NY 489.08M 24.44 −7.42%
CytomX Therapeutics, Inc.CTMX · South San Francisco, CA 527.32M 2.4200 −5.84%
BlossomHill Therapeutics, Inc.BLSM · San Diego, CA 548.93M 17.27 −1.20%
Monopar Therapeutics Inc.MNPR · Wilmette, IL 517.17M 77.05 −2.42%

Healthcare companies of a similar market value (533.39M).

Company Mkt cap Price Today
Delcath Systems, Inc.DCTH · Medical Devices 543.73M 15.67 +2.02%
Bright Minds Biosciences Inc.DRUG · Biotechnology 532.76M 54.01 −0.07%
Puma Biotechnology, Inc.PBYI · Biotechnology 531.17M 10.29 0.00%
Aclaris Therapeutics, Inc.ACRS · Biotechnology 529.92M 3.6000 −6.01%
Crescent Biopharma, Inc.CBIO · Biotechnology 537.14M 14.46 −3.02%
Neurogene Inc.NGNE · Biotechnology 489.08M 24.44 −7.42%
CytomX Therapeutics, Inc.CTMX · Biotechnology 527.32M 2.4200 −5.84%
BlossomHill Therapeutics, Inc.BLSM · Biotechnology 548.93M 17.27 −1.20%

Also based in Rockville, Maryland, then elsewhere in Maryland.

Company Mkt cap Price Today
X-Energy, Inc.XE · Rockville, MD 5.32B 13.08 −4.60%
Supernus Pharmaceuticals, Inc.SUPN · Rockville, MD 2.49B 42.81 +0.33%
CEVA, Inc.CEVA · Rockville, MD 893.89M 31.75 −5.20%
Faeth Therapeutics, Inc.FTH · Rockville, MD 600.79M 23.25 −10.68%
Capital Bancorp, Inc.CBNK · Rockville, MD 634.08M 38.91 +0.96%
MacroGenics, Inc.MGNX · Rockville, MD 236.96M 3.7200 −0.53%
NovaBridge BiosciencesNBP · Rockville, MD 153.12M 1.3200 −5.38%
MaxCyte, Inc.MXCT · Rockville, MD 102.69M 0.9950 −1.49%

The stocks whose daily moves over the past year went most closely with REGENXBIO's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Rocket Pharmaceuticals, Inc.RCKT · Correlation 0.50 272.24M 2.4800 −3.13%
4D Molecular Therapeutics, Inc.FDMT · Correlation 0.46 718.17M 13.00 −2.48%
Ultragenyx Pharmaceutical Inc.RARE · Correlation 0.39 1.51B 15.30 −1.16%
Bright Minds Biosciences Inc.DRUG · Correlation 0.38 532.76M 54.01 −0.07%
Design Therapeutics, Inc.DSGN · Correlation 0.37 682.77M 10.91 −6.35%
MeiraGTx Holdings plcMGTX · Correlation 0.37 996.93M 10.38 −2.90%
Lexeo Therapeutics, Inc.LXEO · Correlation 0.36 249.55M 3.0400 −5.88%
Altimmune, Inc.ALT · Correlation 0.35 497.97M 2.5600 −1.92%

What visitors to REGENXBIO's page also look at.

Company Mkt cap Price Today
Voyager Therapeutics, Inc.VYGR 139.87M 2.2700 −7.35%
uniQure N.V.QURE 1.51B 21.84 −3.32%
MeiraGTx Holdings plcMGTX 996.93M 10.38 −2.90%
Ultragenyx Pharmaceutical Inc.RARE 1.51B 15.30 −1.16%
Xencor, Inc.XNCR 1.86B 25.04 +1.66%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All RGNX news ›
MarketScreener·

REGENXBIO Inc. : Insider Transactions

Follow insider transactions on REGENXBIO Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions REGENXBIO Inc. Biotechnology & Medical Research Latest insider…

MarketScreener·

All Transcripts on REGENXBIO Inc. (RGNX)

Find all the latest transcripts on REGENXBIO Inc. Biotechnology & Medical Research AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers June 22, 2026 at 12:20 pm EDT All financial news and data tailored to…

MarketScreener·Positive

REGENXBIO Inc.: News in other languages | RGNX | US75901B1070

REGENXBIO Inc.: News, information and stories for REGENXBIO Inc. | Nasdaq: RGNX | Nasdaq Other languages REGENXBIO Inc. Biotechnology & Medical Research AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers June…

MarketScreener·Positive

Regenxbio Inc. Announces Board Changes

REGENXBIO Inc. announced the appointment of Greg Ciongoli to its Board of Directors, effective August 25, 2026. Greg Ciongoli is the Founder and Managing Partner of Adiumentum Capital Management, an... announced the appointment of Greg…

MarketScreener·Positive

REGENXBIO Inc.: Latest Headlines - Nasdaq Stock Exchange

Find the latest highlights on REGENXBIO Inc. at the Nasdaq stock exchange. Biotechnology & Medical Research AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers June 22, 2026 at 12:20 pm EDT All financial news and…

MarketScreener·Positive

REGENXBIO Inc.: Official Announcements - Stock Market News

Find the latest press releases and official documents published by REGENXBIO Inc. on MarketScreener. Press Releases REGENXBIO Inc. Biotechnology & Medical Research AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock…

MarketScreener·

REGENXBIO Inc.: Relative Strength Chart - Stock Nasdaq

Compare REGENXBIO Inc. with the company of your choice via a Relative Strength chart. Real-time RGNX price, Nasdaq stock exchange Relative Strength Chart REGENXBIO Inc. Biotechnology & Medical Research All financial news and data tailored…

MarketScreener·

Regenxbio Provides Regulatory Update on Rgx-121 for Mps Ii

REGENXBIO Inc. provided an update on its investigational gene therapy, RGX-121 , for the treatment of Mucopolysaccharidosis type II , also known as Hunter Syndrome. The U.S. Food and Drug... provided an update on its investigational gene…

From articles in the 4Search news index.

In the news

24mentions in 30 days
24with it in the headline
Positivesentiment

Mentioned with

Regeneron16Regenxbio Inc.10J.p Morgan Securities Llc9Morgan Stanley9Morgan Stanley & CO Llc9Regeneron Pharmaceuticals, Inc9Regenxbio Inc9Regeneron Pharmaceuticals, Inc.8

People in the coverage

Mitch Edgeman8Hagens Berman7Regenxbio7Danessa Lincoln6Libtayo5Joseph E. Levi4

Themes

Biotechnology10Regn9Biotech8Equities8Healthcare7Corporate Governance6Gene Therapy6Pharmaceuticals6

Most coverage from

  1. marketscreener.com15
  2. seekingalpha.com2
  3. endpoints.news1
  4. grafa.com1
  5. gurufocus.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.